67
Participants
Start Date
April 20, 2009
Primary Completion Date
June 8, 2010
Study Completion Date
June 8, 2010
GSK2190915 Solution.
Aqueous Solution, 10mg/mL.
GSK2190915 Granule Capsule (A)
GSK2190915A granule filled in to Gelatin capsules
GSK2190915 Semi-solid Lipid Capsule (B)
GSK2190915A dispersed in a lipid vehicle and filled in to HPMC capsules
GSK2190915 Liquid Lipid Capsule (C)
GSK2190915A dissolved in lipid vehicle milled and filled in to Gelatin capsules
GSK2190915 Milled Tablet
GSK2190915A granule is blended, compressed into tablets and aqueous film coated
GSK2190915 Micronised Tablet
GSK2190915A granule is blended, compressed into tablets and aqueous film coated
GSK Investigational Site, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY